To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period

Background: Iron deficiency anemia continues to be a serious problem in developing countries resulting spectrum of adverse events pregnant women. The first choice for prophylaxis and treatment mild IDA pregnancy is oral iron therapy. However, patients with moderate severe anemia, therapy takes very long time compliance could big issue our country. Thus, women should better treated parenteral Postpartum were eligible the study hemoglobin level <10 g/dl, while those sickle cell aplastic megaloblastic etc., or having allergy parental considered not this study. randomly categorized receive intravenous sucrose ferrous carboxymaltose. Aims Objectives: (1) To Compare carboxymaltose treating postpartum period (2) assess effects patient compliance. Materials Methods: A comparative, prospective, randomized distributed 50 within Department Obstetrics Gynecology, MGM Medical College Hospital, Navi Mumbai. subjects into two group, group receiving sucrose, whereas second Results: Study, 25 received There was significant higher increase levels at 6 weeks ferric (FCM) as compared levels. ferritin 2 FCM reticulocyte count week count. Conclusion: Ferric safe efficient lesser effect